As of 2026-10-02, the EV/EBITDA ratio of Pulmonx Corp (LUNG) is -1.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LUNG's latest enterprise value is 62.37 mil USD. LUNG's TTM EBITDA according to its financial statements is -43.38 mil USD. Dividing these 2 quantities gives us the above LUNG EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 16.1x | 14.9x |
| Forward P/E multiples | 13.9x - 16.3x | 15.1x |
| Fair Price | (13.84) - (16.10) | (14.97) |
| Upside | -824.6% - -942.9% | -883.7% |
| Date | EV/EBITDA |
| 2026-09-30 | -1.44 |
| 2026-09-29 | -1.51 |
| 2026-09-28 | -1.49 |
| 2026-09-25 | -1.44 |
| 2026-09-24 | -1.43 |
| 2026-09-23 | -1.53 |
| 2026-09-22 | -1.58 |
| 2026-09-21 | -1.52 |
| 2026-09-18 | -1.59 |
| 2026-09-17 | -1.51 |
| 2026-09-16 | -1.48 |
| 2026-09-15 | -1.44 |
| 2026-09-14 | -1.50 |
| 2026-09-11 | -1.38 |
| 2026-09-10 | -1.38 |
| 2026-09-09 | -1.51 |
| 2026-09-08 | -1.60 |
| 2026-09-04 | -1.73 |
| 2026-09-03 | -1.78 |
| 2026-09-02 | -1.80 |
| 2026-09-01 | -1.76 |
| 2026-08-31 | -1.90 |
| 2026-08-28 | -1.90 |
| 2026-08-27 | -1.93 |
| 2026-08-26 | -2.01 |
| 2026-08-25 | -2.01 |
| 2026-08-24 | -1.80 |
| 2026-08-21 | -1.78 |
| 2026-08-20 | -1.82 |
| 2026-08-19 | -1.83 |
| 2026-08-18 | -1.78 |
| 2026-08-17 | -1.75 |
| 2026-08-14 | -1.93 |
| 2026-08-13 | -1.68 |
| 2026-08-12 | -1.81 |
| 2026-08-11 | -1.78 |
| 2026-08-10 | -1.80 |
| 2026-08-07 | -1.56 |
| 2026-08-06 | -1.57 |
| 2026-08-05 | -1.51 |
| 2026-08-04 | -1.58 |
| 2026-08-03 | -1.64 |
| 2026-07-31 | -1.17 |
| 2026-07-30 | -1.15 |
| 2026-07-29 | -0.80 |
| 2026-07-28 | -0.80 |
| 2026-07-27 | -0.77 |
| 2026-07-24 | -0.72 |
| 2026-07-23 | -0.77 |
| 2026-07-22 | -0.76 |